Jordi Craven-Bartle

Hospital de la Santa Creu i Sant Pau

关注

立即认领

关注

立即认领

基本信息

浏览量：26

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 68 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Table S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato,Francesc Alameda,Anna Esteve-Codina,Estela Pineda,Oriol Arpí,Maria Martinez-García,Mar Mallo,Marta Gut,Raquel Lopez-Martos,Sonia Del Barco,Teresa Ribalta,Jaume Capellades,Josep Puig,Oscar Gallego,Carlos Mesia,Ana M Muñoz-Marmol,Ivan Archilla,Montserrat Arumí,Julie Marie Blanc,Beatriz Bellosillo,Silvia Menendez,Anna Esteve,Silvia Bagué,Ainhoa Hernandez,Jordi Craven-Bartle,Rafael Fuentes,Noemí Vidal,Iban Aldecoa,Nuria de la Iglesia,Carmen Balana

openalex（2023）

引用0浏览0引用

Supplementary Fig. S3 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

Supplementary Fig. S4 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

Table S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

Supplementary Data Files S1 A_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

Supplementary Fig. S2 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

Supplementary Fig S1 from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

openalex（2023）

引用0浏览0引用

PO-1280: Six-Years Experience of Peer Review: Analysis of Results and Lessons Learned

J. Perez-Alija,N. Jornet,P. Gallego,A. Latorre-Musoll,P. Carrasco de Fez,P. Delgado-Tapia,P. Simon Garcia,A. Ruiz Martinez,M. Adria Mora,M. Lizondo,I. Valverde-Pascual,M. Barcelo-Pages,N. Garcia-Apellaniz,G. Sancho Pardo,J. Craven-Bartle,M. Ribas

RADIOTHERAPY AND ONCOLOGY（2020）

引用0浏览0引用

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors Are Identifiable by IHC and Have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato,Francesc Alameda,Anna Esteve-Codina,Estela Pineda,Oriol Arpi,Maria Martinez-Garcia,Mar Mallo,Marta Gut,Raquel Lopez-Martos,Sonia Del Barco,Teresa Ribalta,Jaume Capellades,Josep Puig,Oscar Gallego,Carlos Mesia,Ana M. Munoz-Marmol,Ivan Archilla,Montserrat Arumi,Julie Marie Blanc,Beatriz Bellosillo,Silvia Menendez,Anna Esteve,Silvia Bague,Ainhoa Hernandez,Jordi Craven-Bartle,Rafael Fuentes,Noemi Vidal,Iban Aldecoa,Nuria de la Iglesia,Carmen Balana

CLINICAL CANCER RESEARCH（2020）

引用10浏览0WOS引用

RNA Sequencing and Immunohistochemistry Reveal ZFN7 As a Stronger Marker of Survival Than Molecular Subtypes in G-CIMP-negative Glioblastoma

Anna Esteve-Codina,Francesc Alameda,Cristina Carrato,Estela Pineda,Oriol Arpi,Maria Martinez-Garcia,Mar Mallo,Marta Gut,Marc Dabad,Avelina Tortosa,Sonia Del Barco,Jaume Capellades,Josep Puig,Oscar Gallego,Teresa Pujol,Laura Oleaga, Miquel Gil-Gil,Cristian De Quintana-Schmidt,Izaskun Valduvieco,Anna Martinez-Cardus,Beatriz Bellosillo,Ana Maria Munoz-Marmol,Anna Esteve,Marta Domenech,Angels Camins,Jordi Craven-Bartle,Salvador Villa,Jordi Marruecos,Sira Domenech,Nuria de la Iglesia,Carmen Balana

Clinical Cancer Researchno. 2 (2020): 645-655

引用9浏览0WOS引用

加载更多

作者统计

#Papers: 68

#Citation: 888

H-Index: 21

G-Index: 29

Sociability: 6

Diversity: 2

Activity: 0

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn